Belite Financial Statements From 2010 to 2025
| BLTE Stock | USD 67.81 0.37 0.55% |
Check Belite Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Belite Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Belite financial statements analysis is a perfect complement when working with Belite Bio Valuation or Volatility modules.
Belite |
Belite Bio ADR Company Shares Outstanding Analysis
Belite Bio's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Belite Bio Shares Outstanding | 31.84 M |
Most of Belite Bio's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Belite Bio ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Belite Bio ADR has 31.84 M of shares currently outstending. This is 82.36% lower than that of the Biotechnology sector and 70.2% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 94.43% higher than that of the company.
Belite Bio ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Belite Bio's current stock value. Our valuation model uses many indicators to compare Belite Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Belite Bio competition to find correlations between indicators driving Belite Bio's intrinsic value. More Info.Belite Bio ADR is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Belite Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Belite Bio Financial Statements
Belite Bio stakeholders use historical fundamental indicators, such as Belite Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Belite Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Belite Bio's assets and liabilities are reflected in the revenues and expenses on Belite Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Belite Bio ADR. Please read more on our technical analysis and fundamental analysis pages.
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd. Belite Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:Check out the analysis of Belite Bio Correlation against competitors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.